A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Actualización sobre el uso de sulfato de magnesio como neuroprotector en el parto prematuro
2015
Archivos Argentinos de Pediatria
The administration of magnesium sulphate to mothers at risk for preterm birth for fetal neuroprotection has demonstrated to reduce the risk of cerebral palsy and gross motor dysfunction by 30-40%. Although there is controversy regarding the regimen of administration of magnesium sulphate, the gestational age limit, the extent of its potential benefit or even if it provides any benefit, current evidence is enough to support the use of magnesium sulphate in women at imminent risk for preterm
doi:10.5546/aap.2015.345
pmid:26172011
fatcat:uo7y3wg25vdrhbehvmmhbtyjx4